Are serum biomarkers useful in the management of systemic sclerosis‐associated interstitial lung disease?

Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease – frontiers and horizons

Pharmacology & Therapeutics ◽

10.1016/j.pharmthera.2019.05.014 ◽

2019 ◽

Vol 202 ◽

pp. 40-52 ◽

Cited By ~ 7

Author(s):

Adelle S. Jee ◽

Joanne Sahhar ◽

Peter Youssef ◽

Jane Bleasel ◽

Stephen Adelstein ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Idiopathic Pulmonary Fibrosis ◽

Pulmonary Fibrosis ◽

Lung Disease ◽

Serum Biomarkers

Download Full-text

Performance of Candidate Serum Biomarkers for Systemic Sclerosis–Associated Interstitial Lung Disease

Arthritis & Rheumatology ◽

10.1002/art.40815 ◽

2019 ◽

Vol 71 (6) ◽

pp. 972-982 ◽

Cited By ~ 33

Author(s):

Muriel Elhai ◽

Anna Maria Hoffmann‐Vold ◽

Jérôme Avouac ◽

Sonia Pezet ◽

Anne Cauvet ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Serum Biomarkers

Download Full-text

Gastroesophageal Reflux and Serum Biomarkers in Systemic Sclerosis–Associated Interstitial Lung Disease: Comment on the Article by Elhai et al

Arthritis & Rheumatology ◽

10.1002/art.40909 ◽

2019 ◽

Vol 71 (7) ◽

pp. 1203-1204

Author(s):

Sergey Moiseev ◽

Antonina Sosnovskaya ◽

Fatima Chotchaeva ◽

Elena Shchegoleva ◽

Pavel Novikov

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Gastroesophageal Reflux ◽

Lung Disease ◽

Serum Biomarkers

Download Full-text

A Case of Systemic Sclerosis with Interstitial Lung Disease Successfully Treated with Intravenous Cyclophosphamide Pulse Therapy and Oral Azathioprine

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.78.356 ◽

2016 ◽

Vol 78 (4) ◽

pp. 356-361

Author(s):

Kei YAMAUCHI ◽

Katsunari MAKINO ◽

Takamitsu MAKINO ◽

Satoshi FUKUSHIMA ◽

Masatoshi JINNIN ◽

...

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Pulse Therapy ◽

Intravenous Cyclophosphamide ◽

Cyclophosphamide Pulse Therapy ◽

Cyclophosphamide Pulse

Download Full-text

Improvement of Systemic Sclerosis Complicated with Interstitial Lung Disease by Intravenous Pulse Therapy with Cyclophosphamide

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.68.256 ◽

2006 ◽

Vol 68 (3) ◽

pp. 256-259 ◽

Cited By ~ 1

Author(s):

Yumi MURASE ◽

Jun KURODA ◽

Yoshinao MURO ◽

Yasushi TOMITA

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Pulse Therapy

Download Full-text

Faculty Opinions recommendation of Interstitial lung disease in systemic sclerosis: a simple staging system.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108827.576910 ◽

2008 ◽

Author(s):

Oliver Distler

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Staging System

Download Full-text

Faculty Opinions recommendation of Interstitial lung disease in systemic sclerosis: a simple staging system.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108827.564961 ◽

2008 ◽

Author(s):

Jay H Ryu

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Staging System

Download Full-text

Faculty Opinions recommendation of Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718298173.793516634 ◽

2016 ◽

Author(s):

Cesare Massone

Keyword(s):

Systemic Sclerosis ◽

African Americans ◽

Interstitial Lung Disease ◽

Lung Disease ◽

Caveolin 1

Download Full-text

Faculty Opinions recommendation of Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.723047927.793516627 ◽

2016 ◽

Author(s):

Cesare Massone

Keyword(s):

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease

Download Full-text

Faculty Opinions recommendation of Prevalence, treatment, and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735094847.793568473 ◽

2019 ◽

Author(s):

Todd Bull

Keyword(s):

Pulmonary Hypertension ◽

Systemic Sclerosis ◽

Interstitial Lung Disease ◽

Lung Disease

Download Full-text